|
|
|
|
Vol. 55, Issue 3, 424-431, March 1999
Laboratory of Experimental Medical Oncology, Topoisomerase (topo) II poisons have been categorized into
ATP-independent and -dependent drugs based on in vitro studies. We
investigated drug-induced topoII-DNA complexes in intact cells almost
completely depleted of ATP. Virtually no DNA single-strand breaks
(SSBs), as measured by alkaline elution, were detected in
energy-depleted cells treated with the topoII poisons etoposide, teniposide, daunorubicin, doxorubicin, mitoxantrone, or clerocidin. This inhibition was reversible; subsequent incubation with glucose restored the level of DNA SSBs. The effect of ATP depletion was specific for topoII, because topoI-mediated cleavable complexes induced
by camptothecin were unaffected by ATP depletion. Furthermore, etoposide-induced DNA-protein complexes and DNA double-strand breaks,
as measured by filter elution techniques, and topoII
and -
trapping, as measured by a band depletion assay, were completely inhibited by energy depletion. Differences in drug transport could not
explain the effect of ATP depletion. The topoII poison amsacrine (m-AMSA) was unique with respect to ATP dependence. In
ATP-depleted cells, m-AMSA-induced DNA SSBs, DNA
double-strand breaks, DNA-protein complexes, topoII
and -
trapping were only modestly reduced. The accumulation of
m-AMSA was reduced in ATP-depleted cells, which
indicates that drug transport could contribute to the modest decrease
in m-AMSA-induced cleavable complexes. In conclusion, drug-induced topoII-DNA complexes were completely antagonized in
ATP-depleted cells, except in the case of m-AMSA. One
possible interpretation is that m-AMSA mainly produces
prestrand passage DNA lesions, whereas the other topoII poisons tested
exclusively stabilize poststrand passage DNA lesions in intact cells.
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics
This article has been cited by other articles:
![]() |
L. H. Jensen, A. Renodon-Corniere, I. Wessel, S. W. Langer, B. Sokilde, E. V. Carstensen, M. Sehested, and P. B. Jensen Maleimide Is a Potent Inhibitor of Topoisomerase II in Vitro and in Vivo: A New Mode of Catalytic Inhibition Mol. Pharmacol., May 1, 2002; 61(5): 1235 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gao, K.-C. Huang, E. F. Yamasaki, K. K. Chan, L. Chohan, and R. M. Snapka XK469, a selective topoisomerase IIbeta poison PNAS, October 12, 1999; 96(21): 12168 - 12173. [Abstract] [Full Text] [PDF] |
||||